Labeling for Human Prescription Drug and Biological Products Approved Under the Accelerated Approval Regulatory Pathway
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 4, 2019
April 24, 2020
53afccba-4a69-4547-878f-b1a1b9a1e7b9
Related Documents
QTc Information in Human Prescription Drug and Biological Product Labeling: Guidance for Industry
Guidance DocumentDecember 3, 2025Office of the Commissioner
Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling Good Review Practice
Guidance DocumentMarch 28, 2019Center for Drug Evaluation and Research
Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products: Guidance for Industry
Guidance DocumentMarch 15, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.